BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected - Candlesense
BIOT Mergers

BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected

(NASDAQ:BIOT) Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted

Related Questions

When is BioSig expected to receive final NASDAQ approval and could any delays impact the merger timeline? What are the potential financial and dilution effects of the pending Acquisition Proposal on current shareholders? How might the adjournment of Proposal No. 1 affect short‑term market sentiment and liquidity for BIOT shares?
Find similar articles on Candlesense globenewswire